Facebook Linkedin RSS Twitter Youtube
Home 2024

Genetic diseases

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome
Drug Discovery

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies
GEN Edge

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

RNA Splicing Visualized, Easing the Design of Small-Molecule Modulators
Drug Discovery

RNA Splicing Visualized, Easing the Design of Small-Molecule Modulators

Standardized Cell and Gene Therapy Hub A Call to Action
Bioprocessing

Standardized Cell and Gene Therapy Hub A Call to Action

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy
Drug Discovery

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Mussel-Inspired Polymer Helps Syntis Bio Deliver Drugs by Coating the Intestine
Drug Discovery

Mussel-Inspired Polymer Helps Syntis Bio Deliver Drugs by Coating the Intestine

eePASSIGE Engineers Gene-Sized Edits in Human Cells 
Genome Editing

eePASSIGE Engineers Gene-Sized Edits in Human Cells 

Boosting Retinal Cell Protein Could Represent Therapeutic Approach Against AMD, Preclinical Study Suggests
Featured

Boosting Retinal Cell Protein Could Represent Therapeutic Approach Against AMD, Preclinical Study Suggests

In a First, AAV-Based Gene Therapy Restores Hearing in Both Ears of Children with Hereditary Deafness
Featured

In a First, AAV-Based Gene Therapy Restores Hearing in Both Ears of Children with Hereditary Deafness

123...84Page 1 of 84
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.